KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Work In Process (2016 - 2018)

Emergent BioSolutions (EBS) has 8 years of Work In Process data on record, last reported at $103.2 million in Q4 2018.

  • For Q4 2018, Work In Process rose 34.73% year-over-year to $103.2 million; the TTM value through Dec 2018 reached $103.2 million, up 34.73%, while the annual FY2018 figure was $103.2 million, 34.73% up from the prior year.
  • Work In Process reached $103.2 million in Q4 2018 per EBS's latest filing, up from $64.8 million in the prior quarter.
  • Across five years, Work In Process topped out at $103.2 million in Q4 2018 and bottomed at $14.8 million in Q3 2017.
  • Average Work In Process over 5 years is $44.1 million, with a median of $34.0 million recorded in 2014.
  • Peak YoY movement for Work In Process: crashed 39.59% in 2017, then soared 338.72% in 2018.
  • A 5-year view of Work In Process shows it stood at $33.5 million in 2014, then dropped by 2.29% to $32.7 million in 2015, then tumbled by 39.4% to $19.8 million in 2016, then soared by 286.46% to $76.6 million in 2017, then skyrocketed by 34.73% to $103.2 million in 2018.
  • Per Business Quant database, its latest 3 readings for Work In Process were $103.2 million in Q4 2018, $64.8 million in Q3 2018, and $79.5 million in Q2 2018.